{"id": "1378287851532599300", "creation": 1617444405.0, "user_id": "2826292747", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 1, "like_count": 9, "quote_count": 0}}, "text": "Efficacy of ChAdOx1 nCoV-19 (AZD1222) #vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial https://t.co/53WN3KUbc4 via @TheLancet #COVID19 #variant #AstraZeneca https://t.co/nSiQr5cJDq", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#VARIANT", "#ASTRAZENECA"]}